Steven O. Stapel - Concepedia

Author

Steven O. Stapel

Also Known As

S O Stapel, S STAPEL, S Stapel, S. O. STAPEL, S. O. Stapel, S. Stapel, S.O. Stapel, Steven O Stapel, Steven O. STAPEL, Steven O. Stapel

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Sanquin Dutch Blood Transfusion Society Amsterdam UMC Location University of Amsterdam Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Steven O. Stapel is an author at University of Amsterdam specializing in medicine, allergy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.3K
2	Natural Sciences	5	5	312
3	Engineering	2	2	74
4	Health Sciences	1	1	270
5	Public Health	1	1	16

Steven O. Stapel

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2007	562
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis Marijn Vis, Willem F. Lems, Alexandre E. Voskuyl, Arthritis & Rheumatism	2006	468
Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report* Steven O. Stapel, R Asero, Barbara Ballmer‐Weber, Allergy NutritionFood AllergyClinical SymptomsFood AnalysisImmunology	2008	270
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2009	222
IgE to Bet v 1 and profilin: Cross-reactivity patterns and clinical relevance Jaap H. Akkerdaas, W.A. van Leeuwen, Steven O. Stapel, Journal of Allergy and Clinical Immunology Bet V 1Clinical EvidenceClinical RelevanceEvidence-based MedicineClinical Review	2002	206
The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept Anna Jamnitski, G. M. Bartelds, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2010	177
Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma T C van der Pouw Kraan, L C Boeije, E R de Groot, The Journal of Immunology	1997	174
Tau-crystallin/alpha-enolase: one gene encodes both an enzyme and a lens structural protein. Graeme Wistow, Thomas M. Lietman, Leah A. Williams, The Journal of Cell Biology Glycolytic Enzyme EnolaseProtein AssemblyMolecular BiologyProtein GeneticsEmbryology	1988	158
Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation Mirjam K. de Vries, Steven O. Stapel, Henk de Vrieze, Annals of the Rheumatic Diseases	2007	155
Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis L.L.A. Lecluse, R.J.B. Driessen, Phyllis I. Spuls, Archives of Dermatology	2010	147

Page 1